Anixa Biosciences News

H.C. Wainwright Maintains Anixa Biosciences(ANIX.US) With Buy Rating, Maintains Target Price $7

Moomoo NewsNov 19 06:31 ET

Anixa Biosciences Gains Buy Rating From Yi Chen Amid Promising Cancer Therapy Advances

TipRanksNov 19 06:29 ET

Anixa Biosciences Analyst Ratings

BenzingaNov 11 17:19 ET

Anixa Biosciences Is Maintained at Buy by EF Hutton

Dow JonesSep 24 10:26 ET

Anixa Biosciences Price Target Maintained With a $10.00/Share by EF Hutton

Dow JonesSep 24 10:26 ET

Anixa Biosciences Analyst Ratings

BenzingaSep 24 10:17 ET

H.C. Wainwright Maintains Anixa Biosciences(ANIX.US) With Buy Rating, Maintains Target Price $7

Moomoo NewsSep 16 12:31 ET

Buy Rating Affirmed for Anixa Biosciences Amid Promising CAR-T Therapy Trials and Stable Financials

TipRanksSep 16 12:18 ET

Anixa Biosciences Analyst Ratings

BenzingaAug 7 07:28 ET

Anixa Biosciences Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

Dow JonesJul 24 06:32 ET

H.C. Wainwright Maintains Anixa Biosciences(ANIX.US) With Buy Rating, Maintains Target Price $7

Moomoo NewsJul 24 06:32 ET

Anixa Biosciences Analyst Ratings

BenzingaJul 24 06:21 ET

Buy Rating Affirmed for Anixa Biosciences Amid Promising Cancer Therapy Trials

TipRanksJul 24 06:19 ET

Anixa Biosciences Analyst Ratings

BenzingaJun 10 06:42 ET

Anixa Biosciences Analyst Ratings

BenzingaMar 21 06:34 ET

Anixa Biosciences: A Buy Rating on Strong Financials and Promising Oncology Advances

TipRanksMar 21 06:25 ET

Analysts Conflicted on These Healthcare Names: Anixa Biosciences (ANIX) and InMode (INMD)

TipRanksFeb 13 12:20 ET

Anixa Biosciences Analyst Ratings

BenzingaFeb 13 12:18 ET

HC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $12 Price Target

BenzingaDec 7, 2023 06:28 ET

Anixa Biosciences Analyst Ratings

BenzingaDec 7, 2023 06:26 ET